Mucosal alpha-papillomaviruses are not associated with esophageal squamous cell carcinomas: Lack of mechanistic evidence from South Africa, China and Iran and from a world-wide meta-analysis

International Journal of Cancer

Volumn 139, Issue 1, 2016, Pages 85-98

  Halec, Gordana ^a,b   Schmitt, Markus ^a   Egger, Sam ^c   Abnet, Christian C ^d   Babb, Chantal ^e   Dawsey, Sanford M ^d   Flechtenmacher, Christa ^f   Gheit, Tarik ^g   Hale, Martin ^e,h   Holzinger, Dana ^a   Malekzadeh, Reza ⁱ   Taylor, Philip R ^d   Tommasino, Massimo ^g   Urban, Margaret I ^e,h   Waterboer, Tim ^a   Pawlita, Michael ^a   Sitas, Freddy ^c,j,k  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CANCER RESEARCH DIVISION   (Australia)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h UNIVERSITY OF THE WITWATERSRAND   (South Africa)

ⁱ TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^j UNIVERSITY OF SYDNEY   (Australia)

^k UNIVERSITY OF NEW SOUTH WALES   (Australia)

more..

Author keywords

esophageal cancer; HPV RNA; HPV transformed phenotype; human papillomavirus; meta analysis; p16INK4; serology

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; UBIQUITIN C; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; CANCER INCIDENCE; CHINA; ENZYME INDUCTION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPING TECHNIQUE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS DNA TEST; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRAN; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SOUTH AFRICA; VIRUS LOAD; WART VIRUS; AGED; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENETICS; GENOTYPE; META ANALYSIS; MIDDLE AGED; PATHOGENICITY; VIROLOGY;

AGED; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; IRAN; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; SOUTH AFRICA;

EID: 84958074065     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29911     Document Type: Article

References (98)

1. Ferlay J, Shin HR, Bray F, et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Jemal A, Tiwari RC, Murray T, et al., Cancer statistics, 2004. CA: Cancer J Clinic 2004; 54: 8-29.
3. Eslick GD,. Epidemiology of esophageal cancer. Gastroenterol Clin North Am 2009; 38: 17-25.
4. IARC. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. A review of human carcinogens-Part B: biological agents 2011; 100B: 1-475.
5. Freedman ND, Abnet CC, Leitzmann MF, et al., A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 2007; 165: 1424-33.
6. Sitas F, Egger S, Urban MI, et al., InterSCOPE study: Associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012; 104: 147-58.
7. Syrjanen K, Pyrhonen S, Aukee S, et al., Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982; 5: 291-6.
8. Syrjanen KJ., Histological changes identical to those of condylomatous lesions found in esophageal squamous cell carcinomas. Archiv Fur Geschwulstforschung 1982; 52: 283-92.
9. Syrjanen KJ., HPV infections and oesophageal cancer. J Clin Pathol 2002; 55: 721-8.
10. Liu H, Li J, Diao M, et al., Statistical analysis of human papillomavirus in a subset of upper aerodigestive tract tumors. J Med Virol 2013; 85: 1775-85
11. Jalilvand S, Shoja Z, Hamkar R., Human papillomavirus burden in different cancers in Iran: a systematic assessment. Asian Pacific journal of cancer prevention: APJCP 2014; 15: 7029-35.
12. Chang F, Syrjanen S, Shen Q, et al., Human papillomavirus involvement in esophageal precancerous lesions and squamous cell carcinomas as evidenced by microscopy and different DNA techniques. Scand J Gastroenterol 1992; 27: 553-63.
13. Peixoto Guimaraes D, Hsin Lu S, Snijders P, et al., Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China. Cancer Lett 2001; 162: 231-5.
14. Matsha T, Donninger H, Erasmus RT, et al., Expression of p53 and its homolog, p73, in HPV DNA positive oesophageal squamous cell carcinomas. Virology 2007; 369: 182-90.
15. Koshiol J, Wei WQ, Kreimer AR, et al., No role for human papillomavirus in esophageal squamous cell carcinoma in China. Int J Cancer 2010; 127: 93-100.
16. Patel K, Mining S, Wakhisi J, et al., TP53 mutations, human papilloma virus DNA and inflammation markers in esophageal squamous cell carcinoma from the Rift Valley, a high-incidence area in Kenya. BMC Res Notes 2011; 4: 469.
17. Haeri H, Mardany O, Asadi-Amoli F, et al., Human papilloma virus and esophageal squamous cell carcinoma. Acta Medica Iranica 2013; 51: 242-5.
18. Howley PM, Munger K, Romanczuk H, et al., Cellular targets of the oncoproteins encoded by the cancer associated human papillomaviruses. Princess Takamatsu Symposia 1991; 22: 239-48.
19. Nakagawa S, Yoshikawa H, Yasugi T, et al., Ubiquitous presence of E6 and E7 transcripts in human papillomavirus-positive cervical carcinomas regardless of its type. J Med Virol 2000; 62: 251-8.
20. Schmitt M, Pawlita M., The HPV transcriptome in HPV16 positive cell lines. Mol Cell Probes 2011; 25: 108-13.
21. zur Hausen H., Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002; 2: 342-50.
22. Halec G, Alemany L, Lloveras B, et al., Pathogenic role of the eight probably/possibly carcinogenic HPV types 26, 53, 66, 67, 68, 70, 73 and 82 in cervical cancer. J Pathol 2014; 234: 441-51.
23. Schmitt M, Depuydt C, Benoy I, et al., Viral load of high-risk human papillomaviruses as reliable clinical predictor for the presence of cervical lesions. Cancer Epidemiol Biomarkers Prev 2013; 22: 406-14.
24. Halec G, Schmitt M, Dondog B, et al., Biological activity of probable/possible high-risk human papillomavirus types in cervical cancer. Int J Cancer 2013; 132: 63-71.
25. Sano T, Masuda N, Oyama T, et al., Overexpression of p16 and p14ARF is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 2002; 52: 375-83.
26. Jung AC, Briolat J, Millon R, et al., Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010; 126: 1882-94.
27. Holzinger D, Schmitt M, Dyckhoff G, et al., Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement. Cancer Res 2012; 72: 4993-5003.
28. Chernock RD, Wang X, Gao G, et al., Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol 2013; 26: 223-31.
29. Halec G, Holzinger D, Schmitt M, et al., Biological evidence for a causal role of HPV16 in a small fraction of laryngeal squamous cell carcinoma. Brit J Cancer 2013; 109: 172-83.
30. Shen Z, Cen S, Shen J, et al., Study of immortalization and malignant transformation of human embryonic esophageal epithelial cells induced by HPV18 E6E7. J Cancer Res Clin Oncol 2000; 126: 589-94.
31. Wong FH, Hu CP, Chen SC, et al., Absence of genomes of DNA tumor viruses and expression of oncogenes and growth factors in two esophageal carcinoma cell lines of Chinese origin. Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi = Chin J Microbiol Immunol 1992; 25: 59-68.
32. Zhang H, Jin Y, Chen X, et al., Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation. Cancer Lett 2007; 245: 184-94.
33. Dreilich M, Bergqvist M, Moberg M, et al., High-risk human papilloma virus (HPV) and survival in patients with esophageal carcinoma: a pilot study. BMC Cancer 2006; 6: 94.
34. Shuyama K, Castillo A, Aguayo F, et al., Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Brit J Cancer 2007; 96: 1554-9.
35. Si HX, Tsao SW, Poon CS, et al., Viral load of HPV in esophageal squamous cell carcinoma. Int J Cancer 2003; 103: 496-500.
36. Zhang D, Zhang Q, Zhou L, et al., Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. BMC Cancer 2010; 10: 650.
37. Zhou XB, Guo M, Quan LP, et al., Detection of human papillomavirus in Chinese esophageal squamous cell carcinoma and its adjacent normal epithelium. World J Gastroenterol 2003; 9: 1170-3.
38. Antonsson A, Nancarrow DJ, Brown IS, et al., High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2010; 19: 2080-7.
39. Bellizzi AM, Woodford RL, Moskaluk CA, et al., Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers. Am J Surg Pathol 2009; 33: 1608-14.
40. Cao F, Han H, Zhang F, et al., HPV infection in esophageal squamous cell carcinoma and its relationship to the prognosis of patients in northern China. Sci World J 2014; 2014: 804738.
41. Herbster S, Ferraro CT, Koff NK, et al., HPV infection in Brazilian patients with esophageal squamous cell carcinoma: interpopulational differences, lack of correlation with surrogate markers and clinicopathological parameters. Cancer Lett 2012; 326: 52-8.
42. Castillo A, Aguayo F, Koriyama C, et al., Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile. World J Gastroenterol 2006; 12: 6188-92.
43. Castillo A, Koriyama C, Higashi M, et al., Human papillomavirus in upper digestive tract tumors from three countries. World J Gastroenterol 2011; 17: 5295-304.
44. Ding GC, Ren JL, Chang FB, et al., Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancers. World J Gastroenterol 2010; 16: 5901-6.
45. Doxtader EE, Katzenstein AL., The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases. Hum Pathol 2012; 43: 327-32.
46. Lofdahl HE, Du J, Nasman A, et al., Prevalence of human papillomavirus (HPV) in oesophageal squamous cell carcinoma in relation to anatomical site of the tumour. PloS One 2012; 7: e46538.
47. Malik SM, Nevin DT, Cohen S, et al., Assessment of immunohistochemistry for p16INK4 and high-risk HPV DNA by in situ hybridization in esophageal squamous cell carcinoma. Int J Surg Pathol 2011; 19: 31-4.
48. Teng H, Li X, Liu X, et al., The absence of human papillomavirus in esophageal squamous cell carcinoma in East China. Int J Clin Exp Pathol 2014; 7: 4184-93.
49. Vaiphei K, Kochhar R, Bhardawaj S, et al., High prevalence of human papillomavirus in esophageal squamous cell carcinoma: a study in paired samples. ISDE 2013; 26: 282-7.
50. Meschede W, Zumbach K, Braspenning J, et al., Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998; 36: 475-80.
51. Heideman DA, Waterboer T, Pawlita M, et al., Human papillomavirus-16 is the predominant type etiologically involved in penile squamous cell carcinoma. J Clin Oncol 2007; 25: 4550-6.
52. Zumbach K, Hoffmann M, Kahn T, et al., Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma. Int J Cancer 2000; 85: 815-8.
53. Kreimer AR, Johansson M, Waterboer T, et al., Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013; 31: 2708-15.
54. Gheit T, Landi S, Gemignani F, et al., Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol 2006; 44: 2025-31.
55. Schmitt M, Dondog B, Waterboer T, et al., Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay. J Clin Microbiol 2010; 48: 143-9.
56. Gheit T, Tommasino M., Detection of high-risk mucosal human papillomavirus DNA in human specimens by a novel and sensitive multiplex PCR method combined with DNA microarray. Methods Mol Biol 2011; 665: 195-212.
57. Holzinger D, Flechtenmacher C, Henfling N, et al., Identification of oropharyngeal squamous cell carcinomas with active HPV16 involvement by immunohistochemical analysis of the retinoblastoma protein pathway. Int J Cancer 2013; 133: 1389-99.
58. DerSimonian R, Laird N., Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
59. Higgins JP, Thompson SG, Deeks JJ, et al., Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
60. Sterne JA, Egger M, Smith GD., Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysis. BMJ 2001; 323: 101-5.
61. Gillison ML, Broutian T, Pickard RK, et al., Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012; 307: 693-703.
62. Smelov V, Eklund C, Muhr LS, et al., 44. Detection of the human papillomavirus infection (HPV) on the internationally used environmental surfaces: ready for a take-off. Sexual Health 2013; 10: 591.
63. Boyd AS, Annarella M, Rapini RP, et al., False-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure. J Am Acad Dermatol 1996; 35: 42-6.
64. Schafer G, Kabanda S, van Rooyen B, et al., The role of inflammation in HPV infection of the Oesophagus. BMC Cancer 2013; 13: 185.
65. Fakhry C, Gillison ML, D'Souza G., Tobacco use and oral HPV-16 infection. JAMA 2014; 312: 1465-7.
66. Gillison ML, Zhang Q, Jordan R, et al., Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 2012; 30: 2102-11.
67. Kumar B, Cordell KG, Lee JS, et al., EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-37.
68. Hoff CM, Grau C, Overgaard J., Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma-a prospective study. Radiother Oncol 2012; 103: 38-44.
69. Casalegno JS, Le Bail Carval K, Eibach D, et al., High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PloS One 2012; 7: e48137.
70. Ma ST, Yeung AC, Chan PK, et al., Transvaginal ultrasound probe contamination by the human papillomavirus in the emergency department. Emerg Med J 2013; 30: 472-5.
71. M'Zali F, Bounizra C, Leroy S, et al., Persistence of microbial contamination on transvaginal ultrasound probes despite low-level disinfection procedure. PloS One 2014; 9: e93368.
72. Seifi S, Asvadi Kermani I, Dolatkhah R, et al., Prevalence of oral human papilloma virus in healthy individuals in East azerbaijan province of iran. Iran J Public Health 2013; 42: 79-85.
73. Bottalico D, Chen Z, Dunne A, Ostoloza J, McKinney S, Sun C, Schlecht NF, Fatahzadeh M, Herrero R, Schiffman M, Burk RD,. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J Infect Dis 2011; 204: 787-92.
74. Dona MG, Gheit T, Latini A, et al., Alpha, beta and gamma Human Papillomaviruses in the anal canal of HIV-infected and uninfected men who have sex with men. J Infect 2015; 71: 74-84.
75. Viarisio D, Mueller-Decker K, Kloz U, et al., E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice. PLoS Pathog 2011; 7: e1002125.
76. Viarisio D, Decker KM, Aengeneyndt B, et al., Human papillomavirus type 38 E6 and E7 act as tumour promoters during chemically induced skin carcinogenesis. J Gen Virol 2013; 94: 749-52.
77. Buitrago-Perez A, Hachimi M, Duenas M, et al., A humanized mouse model of HPV-associated pathology driven by E7 expression. PloS One 2012; 7: e41743.
78. Saidj D, Cros MP, Hernandez-Vargas H, et al., Oncoprotein E7 from beta human papillomavirus 38 induces formation of an inhibitory complex for a subset of p53-regulated promoters. J Virol 2013; 87: 12139-50.
79. Wallace NA, Robinson K, Galloway DA., Beta human papillomavirus E6 expression inhibits stabilization of p53 and increases tolerance of genomic instability. J Virol 2014; 88: 6112-27.
80. Holloway A, Simmonds M, Azad A, et al., Resistance to UV-induced apoptosis by beta-HPV5 E6 involves targeting of activated BAK for proteolysis by recruitment of the HERC1 ubiquitin ligase. Int J Cancer 2015; 136: 2831-43.
81. Guo F, Liu Y, Wang X, et al., Human papillomavirus infection and esophageal squamous cell carcinoma: a case-control study. Cancer Epidemiol Biomarkers Prev 2012; 21: 780-5.
82. Anantharaman D, Gheit T, Waterboer T, et al., No causal association identified for human papillomavirus infections in lung cancer. Cancer Res 2014; 74: 3525-34.
83. Hoffmann M, Tribius S, Quabius ES, et al., HPV DNA, E6∗I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer-how valid is p16INK4A as surrogate marker? Cancer Lett 2012; 323: 88-96.
84. Lassen P, Eriksen JG, Hamilton-Dutoit S, et al., Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-8.
85. Lassen P, Primdahl H, Johansen J, et al., Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol 2014; 113: 310-6.
86. Munger K, Gwin TK, McLaughlin-Drubin ME., p16 in HPV-associated cancers. Oncotarget 2013; 4: 1864-5.
87. McLaughlin-Drubin ME, Park D, Munger K., Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines. Proc Natl Acad Sci USA 2013; 110: 16175-80.
88. von Knebel Doeberitz M, Gissmann L., Analysis of the biological role of human papilloma virus (HPV)-encoded transcripts in cervical carcinoma cells by antisense RNA. Haematol Blood Transfus 1987; 31: 377-9.
89. Hirama T, Miller CW, Wilczynski SP, et al., p16 (CDKN2/cyclin-dependent kinase-4 inhibitor/multiple tumor suppressor-1) gene is not altered in uterine cervical carcinomas or cell lines. Mod Pathol 1996; 9: 26-31.
90. Jiang M, Milner J., Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002; 21: 6041-8.
91. Magaldi TG, Almstead LL, Bellone S, et al., Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation. Virology 2012; 422: 114-24.
92. Cancer Genome Atlas N., Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature 2015; 517: 576-82.
93. Yildiz IZ, Usubutun A, Firat P, et al., Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature. Pathol Res Pract 2007; 203: 445-9.
94. Srivastava S., P16INK4A and MIB-1: an immunohistochemical expression in preneoplasia and neoplasia of the cervix. Indian J Pathol Microbiol 2010; 53: 518-24.
95. Cheah PL, Looi LM, Mun KS, et al., Implications of continued upregulation of p16(INK4a) through the evolution from high-grade squamous intraepithelial lesion to invasive squamous carcinoma of the cervix. Malays J Pathol 2011; 33: 83-7.
96. Michaelsen SH, Larsen CG, von Buchwald C., Human papillomavirus shows highly variable prevalence in esophageal squamous cell carcinoma and no significant correlation to p16INK4a overexpression: a systematic review. J Thorac Oncol 2014; 9: 865-71.
97. Carozzi F, Gillio-Tos A, Confortini M, et al., Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol 2013; 14: 168-76.
98. Rautava J, Syrjanen S., Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol 2012; 6 Suppl 1: S3-15.